This bulletin was published on 19 June
PSCI Endorses Converge Supplier Initiative to Cut Scope 3 Emissions in Pharma

PSCI Endorses Converge Supplier Initiative to Cut Scope 3 Emissions in Pharma

The PSCI has endorsed My Green Lab's Converge Supplier Initiative, a unique industry collaboration designed to support pharmaceutical suppliers in achieving My Green Lab® Certification.

The Converge Supplier Initiative is a unique industry collaboration designed to support pharmaceutical suppliers—including Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and Contract Development & Manufacturing Organizations (CDMOs)—in achieving My Green Lab® Certification. This certification framework enables suppliers to reduce environmental impact, cut energy and water use, lower costs, and align lab operations with corporate sustainability goals. This endorsement from the PSCI underscores growing momentum across the pharmaceutical industry to reduce supply chain (Scope 3) emissions and foster more sustainable lab operations.

Leading pharmaceutical companies, including AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, GSK, MilliporeSigma, Takeda, and UCB, have not only walked the talk by implementing My Green Lab Certification in their own labs to drive down emissions, but also have joined forces to educate and empower their outsourced research partners through the Converge Supplier Initiative. To date, over 147 supplier organizations have joined the initiative, with 32 already completing pilot certifications.

“The research supply chain represents a significant portion of the pharmaceutical industry’s environmental footprint,” said James Connelly, CEO of My Green Lab. “This endorsement by PSCI reinforces the power of collaborative action and positions the Converge Supplier Initiative as a proven, scalable solution for driving impact reduction on the ground in the labs across the industry.”

PSCI unites pharmaceutical and healthcare companies to advance responsible supply chain practices and drive improved safety, environmental, and social outcomes across the global value chain. Together, PSCI and My Green Lab are aligned in their vision for a more sustainable and collaborative future in science.

“Bristol Myers Squibb is excited to see two important relationships come together with PSCI and Converge. With Converge providing a hands-on, practical approach for suppliers with lab operations to address their footprint through My Green Lab Certification, it dovetails well with PSCI’s drive to see the adoption of sustainable practices in pharmaceutical supply chains. This partnership can accelerate the critical need for pharmaceutical supply chains to reduce their footprint while continuing their missions of delivering for patients,” said Devin Carsdale, Associate Director of Sustainability at Bristol Myers Squibb and PSCI Decarbonization Team Co-Lead.

"We proudly operate 17 labs globally, all of which have achieved My Green Lab Certification," said Bill Sterling, Senior Director of Global Environmental Health and Safety, IQVIA Laboratories. "The My Green Lab program has been instrumental in fostering a culture of sustainability and engaging employees at all sites. It helps support our mission to accelerate innovation for a healthier world and features prominently in our annual sustainability report.”

PSCI’s endorsement also supports the broader United Nations-backed Race to Zero campaign, which calls for 95% of participating organizations’ laboratories globally to achieve My Green Lab Certification at the highest 'Green' Level by 2030, a critical milestone in the path of net-zero emissions in science.

Learn more about My Green Lab Certification here.